LIQUID FORMULATION OF ANTI-TNF ALPHA ANTIBODY

Title:

LIQUID FORMULATION OF ANTI-TNF ALPHA ANTIBODY

Document Type and Number:

WIPO Patent Application WO/2018/169348

Kind Code:

A1

Abstract:

The present invention relates to a liquid formulation of an anti-TNF alpha antibody, particularly adalimumab.

Inventors:

YUN SORA (KR)
KO YOUN KYUNG (KR)
SO JIN EON (KR)

Application Number:

PCT/KR2018/003097

Publication Date:

September 20, 2018

Filing Date:

March 16, 2018

Export Citation:

Assignee:

LG CHEMICAL LTD (KR)

International Classes:

A61K9/08; A61K39/395; A61K47/10; A61K47/18; A61K47/26

Domestic Patent References:

Foreign References:

KR20170005864A	2017-01-16
US20160304599A1	2016-10-20

Attorney, Agent or Firm:

SON, Min (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: OPERATION METHOD OF TERMINAL AND BASE STATION IN WIRELESS COMMUNICATION SYSTEM, AND DEVICE SUPPORTIN...

Next Patent: RADIOMETER AND OPERATING METHOD THEREOF, AND MONITORING SYSTEM USING SAME